December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant

December 09, 2025

External Validation Confirms Ability of AI Model to Stratify Recurrence Risk in Early-Stage Lung Cancer

A machine learning–based survival model, incorporating preoperative CT images and routinely available clinical data, outperformed standard clinical staging systems in predicting recurrence after surge...

The ASCO Post

December 05, 2025

Long-Term Survival With Stereotactic Ablative Radiotherapy vs Surgery for Early-Stage NSCLC

With 10 years of follow-up, no significant difference in survival rates was reported between patients who were treated with stereotactic ablative radiotherapy (SABR) or video-assisted thoracoscopic su...

The ASCO Post

December 02, 2025

Preliminary Activity of LuPSMA-I&T Plus Ra-223 in Metastatic Castration-Resistant Prostate Cancer With Bone Metastasis

In an interim analysis of an Australian single-center phase I/II trial (AlphaBet) reported in The Lancet Oncology, Kostos et al found that the combination of lutetium-177–labeled PSMA-I&T (LuPSMA-...

The ASCO Post

November 24, 2025

ASTRO Publishes First Clinical Guideline on Radiation Therapy for Gastric Cancer

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) is the first to focus on radiation therapy for patients with gastric cancer. The recommendations outline radiation the...

The ASCO Post

November 14, 2025

SABR May Be Comparable to Surgery for Early-Stage NSCLC

Stereotactic ablative radiation therapy (SABR) was found to be noninferior to surgical resection in terms of overall survival for patients with early-stage non–small cell lung cancer (NSCLC), accordin...

The ASCO Post

November 04, 2025

ADA standards on CBCT systems, DICOM available for comment

The draft standards are available for review and comment until Dec. 5.

ADA News

November 04, 2025

$16 Million PRISM Trial Will Explore AI in Breast Cancer Screening

The newly funded, multi-institutional PRISM clinical trial will evaluate whether AI can help support radiologists in interpreting mammograms more accurately, with the goal of improving breast cancer s...

The ASCO Post

October 29, 2025

Hybrid AI Approach With Uncertainty Quantification for Mammography Reading Supports Safe Workload Reduction

Investigators have developed and tested a hybrid reading strategy for screening mammography images with artificial intelligence (AI) that includes reads from radiologists and a stand-alone AI interpre...

The ASCO Post